Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
Drug Approval
|
Mid-range Performer
172.0000
0.68
(
0.40
%)
NSE
Sep 24, 2025
09:58 AM
Near 52W Low of ₹165.52
Volume:
205.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
04 Oct 2023
Drug Approval
172.00
0.40%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 149
Target
Ventura
Consolidating on the back of the Teva acquisition
Marksans Pharma Ltd. is trading below all available SMAs
More from Marksans Pharma Ltd.
Recommended
Market opens lower, Dilip Buildcon's JV bags a Rs 1,115.4 crore order
Trendlyne Marketwatch |
24 Sep 2025, 09:42AM
Five stocks to buy from analysts this week - September 23, 2025
The Baseline |
23 Sep 2025, 06:11PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017